| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Angiography | 78 | 2021 | 866 | 11.640 |
Why?
|
| Tomography, X-Ray Computed | 103 | 2022 | 2324 | 11.530 |
Why?
|
| Computed Tomography Angiography | 68 | 2021 | 424 | 11.350 |
Why?
|
| Coronary Artery Disease | 63 | 2022 | 696 | 8.690 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 26 | 2021 | 92 | 6.240 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 45 | 2020 | 373 | 5.490 |
Why?
|
| Contrast Media | 61 | 2022 | 595 | 5.260 |
Why?
|
| Image Processing, Computer-Assisted | 27 | 2022 | 689 | 4.960 |
Why?
|
| Coronary Stenosis | 25 | 2020 | 246 | 4.770 |
Why?
|
| Coronary Vessels | 28 | 2022 | 313 | 4.300 |
Why?
|
| Myocardial Perfusion Imaging | 17 | 2021 | 100 | 3.990 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2022 | 2223 | 3.930 |
Why?
|
| Artificial Intelligence | 11 | 2023 | 159 | 3.810 |
Why?
|
| Algorithms | 33 | 2023 | 1196 | 3.480 |
Why?
|
| Machine Learning | 14 | 2022 | 170 | 3.220 |
Why?
|
| Radiation Dosage | 33 | 2018 | 419 | 3.090 |
Why?
|
| Reproducibility of Results | 68 | 2021 | 2077 | 2.750 |
Why?
|
| Radiology | 4 | 2020 | 97 | 2.650 |
Why?
|
| Phantoms, Imaging | 7 | 2018 | 189 | 2.560 |
Why?
|
| Vascular Calcification | 19 | 2022 | 131 | 2.450 |
Why?
|
| Radiography, Abdominal | 9 | 2017 | 57 | 2.450 |
Why?
|
| Fractional Flow Reserve, Myocardial | 16 | 2020 | 137 | 2.350 |
Why?
|
| Humans | 227 | 2023 | 68618 | 2.290 |
Why?
|
| Middle Aged | 134 | 2023 | 21147 | 2.280 |
Why?
|
| Heart | 19 | 2023 | 850 | 2.230 |
Why?
|
| Sensitivity and Specificity | 44 | 2021 | 1753 | 2.200 |
Why?
|
| Radiographic Image Enhancement | 15 | 2018 | 208 | 2.120 |
Why?
|
| Male | 150 | 2023 | 37321 | 2.040 |
Why?
|
| Aged | 91 | 2023 | 14862 | 1.820 |
Why?
|
| Iodine | 6 | 2021 | 42 | 1.820 |
Why?
|
| Iohexol | 9 | 2018 | 82 | 1.790 |
Why?
|
| Liver Neoplasms | 8 | 2018 | 334 | 1.790 |
Why?
|
| Female | 142 | 2023 | 38074 | 1.770 |
Why?
|
| Plaque, Atherosclerotic | 15 | 2022 | 125 | 1.680 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2019 | 45 | 1.600 |
Why?
|
| Retrospective Studies | 61 | 2022 | 7277 | 1.580 |
Why?
|
| Coronary Circulation | 7 | 2020 | 136 | 1.500 |
Why?
|
| Transcatheter Aortic Valve Replacement | 9 | 2018 | 90 | 1.460 |
Why?
|
| Heart Defects, Congenital | 4 | 2020 | 596 | 1.460 |
Why?
|
| Liver Diseases | 6 | 2016 | 193 | 1.430 |
Why?
|
| Multidetector Computed Tomography | 9 | 2019 | 60 | 1.390 |
Why?
|
| Prospective Studies | 37 | 2020 | 3705 | 1.380 |
Why?
|
| Myocardial Ischemia | 6 | 2022 | 172 | 1.370 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 300 | 1.270 |
Why?
|
| Rectal Neoplasms | 4 | 2017 | 75 | 1.260 |
Why?
|
| Predictive Value of Tests | 33 | 2022 | 1465 | 1.210 |
Why?
|
| Liver | 7 | 2018 | 1118 | 1.180 |
Why?
|
| Aortic Valve Stenosis | 9 | 2017 | 177 | 1.160 |
Why?
|
| Cardiovascular Diseases | 7 | 2022 | 940 | 1.130 |
Why?
|
| Practice Guidelines as Topic | 6 | 2017 | 772 | 1.100 |
Why?
|
| Magnetic Resonance Angiography | 10 | 2019 | 181 | 1.090 |
Why?
|
| Coronary Aneurysm | 2 | 2017 | 19 | 1.090 |
Why?
|
| Prognosis | 26 | 2023 | 2093 | 1.080 |
Why?
|
| Heart Diseases | 7 | 2021 | 276 | 1.070 |
Why?
|
| Electrocardiography | 12 | 2017 | 601 | 1.060 |
Why?
|
| Exercise Test | 7 | 2019 | 242 | 1.030 |
Why?
|
| Artifacts | 8 | 2019 | 125 | 1.020 |
Why?
|
| Myocardium | 13 | 2022 | 1204 | 1.020 |
Why?
|
| Radiography, Thoracic | 3 | 2022 | 99 | 1.010 |
Why?
|
| Calcinosis | 5 | 2018 | 241 | 0.990 |
Why?
|
| Signal-To-Noise Ratio | 12 | 2018 | 93 | 0.950 |
Why?
|
| Heart Ventricles | 5 | 2016 | 738 | 0.930 |
Why?
|
| Adult | 54 | 2021 | 21403 | 0.930 |
Why?
|
| Mitral Valve | 2 | 2015 | 166 | 0.930 |
Why?
|
| Obesity | 3 | 2016 | 1076 | 0.920 |
Why?
|
| Aged, 80 and over | 28 | 2021 | 4848 | 0.920 |
Why?
|
| Radiologists | 2 | 2022 | 35 | 0.890 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 1173 | 0.870 |
Why?
|
| Aorta, Abdominal | 2 | 2021 | 97 | 0.850 |
Why?
|
| Preoperative Care | 4 | 2019 | 275 | 0.820 |
Why?
|
| Myocarditis | 2 | 2020 | 49 | 0.810 |
Why?
|
| Echocardiography | 5 | 2021 | 515 | 0.800 |
Why?
|
| ROC Curve | 17 | 2020 | 392 | 0.800 |
Why?
|
| Angiography, Digital Subtraction | 4 | 2019 | 63 | 0.760 |
Why?
|
| Endoleak | 1 | 2021 | 23 | 0.750 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2018 | 333 | 0.740 |
Why?
|
| Hyperemia | 1 | 2020 | 14 | 0.710 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2021 | 139 | 0.680 |
Why?
|
| Severity of Illness Index | 21 | 2021 | 1851 | 0.680 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2015 | 277 | 0.680 |
Why?
|
| Body Mass Index | 5 | 2018 | 867 | 0.680 |
Why?
|
| Neoadjuvant Therapy | 3 | 2017 | 104 | 0.660 |
Why?
|
| Positron-Emission Tomography | 4 | 2021 | 160 | 0.660 |
Why?
|
| Angiography | 6 | 2014 | 194 | 0.660 |
Why?
|
| Stents | 4 | 2016 | 657 | 0.660 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 4 | 2021 | 137 | 0.650 |
Why?
|
| Iopamidol | 6 | 2015 | 37 | 0.650 |
Why?
|
| Observer Variation | 13 | 2017 | 330 | 0.640 |
Why?
|
| Lung Diseases | 2 | 2018 | 175 | 0.640 |
Why?
|
| Chemoradiotherapy | 2 | 2016 | 54 | 0.630 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2017 | 141 | 0.630 |
Why?
|
| Multimodal Imaging | 2 | 2016 | 62 | 0.630 |
Why?
|
| Gadolinium | 7 | 2022 | 88 | 0.630 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2015 | 23 | 0.620 |
Why?
|
| Melanoma | 1 | 2022 | 335 | 0.620 |
Why?
|
| Cardiac Imaging Techniques | 3 | 2018 | 35 | 0.590 |
Why?
|
| Software | 5 | 2020 | 418 | 0.580 |
Why?
|
| Male Urogenital Diseases | 1 | 2017 | 2 | 0.580 |
Why?
|
| Female Urogenital Diseases | 1 | 2017 | 5 | 0.570 |
Why?
|
| Digestive System Diseases | 1 | 2017 | 16 | 0.570 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2016 | 164 | 0.570 |
Why?
|
| Risk Assessment | 18 | 2022 | 2007 | 0.570 |
Why?
|
| Magnetic Resonance Imaging, Cine | 7 | 2023 | 83 | 0.560 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 366 | 0.550 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 45 | 0.550 |
Why?
|
| Vascular Diseases | 1 | 2017 | 94 | 0.550 |
Why?
|
| Pericardium | 5 | 2019 | 97 | 0.530 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 85 | 0.520 |
Why?
|
| Diverticulum, Colon | 1 | 2015 | 3 | 0.520 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 450 | 0.510 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 167 | 0.510 |
Why?
|
| Risk Factors | 21 | 2023 | 5731 | 0.510 |
Why?
|
| Radiation Protection | 6 | 2016 | 71 | 0.510 |
Why?
|
| Workflow | 3 | 2020 | 100 | 0.500 |
Why?
|
| Adipose Tissue | 4 | 2020 | 221 | 0.500 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 182 | 0.490 |
Why?
|
| Pulmonary Artery | 3 | 2019 | 323 | 0.490 |
Why?
|
| Cardiac-Gated Imaging Techniques | 7 | 2017 | 60 | 0.490 |
Why?
|
| Endometriosis | 4 | 2019 | 56 | 0.490 |
Why?
|
| Heart Aneurysm | 1 | 2014 | 21 | 0.490 |
Why?
|
| Myocardial Infarction | 5 | 2019 | 807 | 0.490 |
Why?
|
| Heart Transplantation | 7 | 2012 | 328 | 0.480 |
Why?
|
| Biliary Tract Diseases | 1 | 2013 | 50 | 0.450 |
Why?
|
| Body Burden | 1 | 2013 | 27 | 0.450 |
Why?
|
| Aortic Diseases | 2 | 2014 | 113 | 0.450 |
Why?
|
| Coronary Disease | 2 | 2014 | 358 | 0.440 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2015 | 116 | 0.430 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2016 | 163 | 0.430 |
Why?
|
| Models, Cardiovascular | 2 | 2011 | 133 | 0.430 |
Why?
|
| Professional Competence | 1 | 2013 | 100 | 0.430 |
Why?
|
| Feasibility Studies | 9 | 2021 | 652 | 0.430 |
Why?
|
| Calcium | 7 | 2022 | 929 | 0.420 |
Why?
|
| Lower Extremity | 4 | 2019 | 153 | 0.420 |
Why?
|
| Aortic Valve | 5 | 2018 | 249 | 0.420 |
Why?
|
| Aorta, Thoracic | 2 | 2011 | 211 | 0.420 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2011 | 134 | 0.420 |
Why?
|
| Asia | 5 | 2019 | 59 | 0.400 |
Why?
|
| Pulmonary Embolism | 4 | 2021 | 253 | 0.400 |
Why?
|
| Diagnostic Imaging | 4 | 2015 | 201 | 0.400 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 38 | 0.390 |
Why?
|
| Young Adult | 13 | 2020 | 5717 | 0.390 |
Why?
|
| Europe | 5 | 2019 | 196 | 0.390 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2021 | 81 | 0.390 |
Why?
|
| Aortography | 4 | 2017 | 72 | 0.390 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 114 | 0.390 |
Why?
|
| Chest Pain | 3 | 2020 | 151 | 0.380 |
Why?
|
| Aortic Aneurysm | 2 | 2016 | 77 | 0.380 |
Why?
|
| Finite Element Analysis | 1 | 2011 | 55 | 0.370 |
Why?
|
| Hepatic Artery | 2 | 2016 | 25 | 0.370 |
Why?
|
| Adolescent | 14 | 2021 | 8912 | 0.360 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2020 | 75 | 0.360 |
Why?
|
| Radiation Exposure | 5 | 2018 | 84 | 0.360 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 442 | 0.360 |
Why?
|
| Hematoma | 1 | 2010 | 47 | 0.360 |
Why?
|
| Atherosclerosis | 2 | 2022 | 204 | 0.350 |
Why?
|
| Diverticular Diseases | 2 | 2020 | 2 | 0.350 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2017 | 239 | 0.330 |
Why?
|
| Registries | 6 | 2021 | 733 | 0.330 |
Why?
|
| Internationality | 3 | 2019 | 74 | 0.330 |
Why?
|
| Prevalence | 7 | 2019 | 1619 | 0.330 |
Why?
|
| Computer Simulation | 2 | 2021 | 706 | 0.330 |
Why?
|
| Tomography, Spiral Computed | 5 | 2019 | 57 | 0.320 |
Why?
|
| Defibrillators, Implantable | 2 | 2023 | 329 | 0.320 |
Why?
|
| Pilot Projects | 3 | 2021 | 1342 | 0.310 |
Why?
|
| Image Enhancement | 4 | 2017 | 143 | 0.310 |
Why?
|
| Radiography | 6 | 2021 | 572 | 0.300 |
Why?
|
| Periodicals as Topic | 2 | 2021 | 158 | 0.300 |
Why?
|
| Treatment Outcome | 13 | 2017 | 7029 | 0.290 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2017 | 137 | 0.290 |
Why?
|
| Coronary Restenosis | 2 | 2017 | 42 | 0.280 |
Why?
|
| Pyrazoles | 3 | 2021 | 190 | 0.280 |
Why?
|
| Adenosine | 3 | 2016 | 165 | 0.270 |
Why?
|
| Colon | 2 | 2018 | 168 | 0.260 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 438 | 0.260 |
Why?
|
| Pelvis | 2 | 2017 | 38 | 0.250 |
Why?
|
| Acute Coronary Syndrome | 2 | 2017 | 195 | 0.250 |
Why?
|
| United States | 9 | 2020 | 7367 | 0.230 |
Why?
|
| Ventricular Function, Left | 4 | 2023 | 481 | 0.220 |
Why?
|
| Life | 1 | 2003 | 1 | 0.220 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 475 | 0.220 |
Why?
|
| Clinical Competence | 3 | 2019 | 657 | 0.220 |
Why?
|
| Euthanasia | 1 | 2003 | 14 | 0.220 |
Why?
|
| Tin | 3 | 2018 | 16 | 0.220 |
Why?
|
| Death | 1 | 2003 | 38 | 0.210 |
Why?
|
| Neoplasms | 2 | 2019 | 1667 | 0.210 |
Why?
|
| Hemodynamics | 4 | 2020 | 705 | 0.210 |
Why?
|
| Homicide | 1 | 2003 | 59 | 0.210 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1553 | 0.210 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 3259 | 0.210 |
Why?
|
| Abdomen | 2 | 2016 | 80 | 0.210 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 12 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 3 | 2019 | 504 | 0.200 |
Why?
|
| Survival Rate | 4 | 2019 | 1056 | 0.200 |
Why?
|
| Foreign Bodies | 2 | 2014 | 58 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 332 | 0.200 |
Why?
|
| Acute Kidney Injury | 2 | 2015 | 232 | 0.200 |
Why?
|
| Incidence | 2 | 2017 | 1603 | 0.200 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2023 | 117 | 0.200 |
Why?
|
| Latent Tuberculosis | 1 | 2021 | 13 | 0.200 |
Why?
|
| Injections | 2 | 2020 | 119 | 0.200 |
Why?
|
| Ovarian Diseases | 2 | 2019 | 7 | 0.190 |
Why?
|
| Stroke Volume | 5 | 2023 | 586 | 0.190 |
Why?
|
| Laparoscopy | 2 | 2013 | 237 | 0.190 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2021 | 106 | 0.180 |
Why?
|
| Mesenteric Arteries | 2 | 2013 | 29 | 0.180 |
Why?
|
| North America | 2 | 2019 | 112 | 0.180 |
Why?
|
| Lymph Nodes | 1 | 2021 | 258 | 0.180 |
Why?
|
| Standard of Care | 1 | 2020 | 22 | 0.180 |
Why?
|
| Athletes | 1 | 2020 | 40 | 0.180 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2013 | 186 | 0.180 |
Why?
|
| Myocardial Revascularization | 2 | 2017 | 56 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2022 | 215 | 0.180 |
Why?
|
| Adipose Tissue, Beige | 1 | 2019 | 1 | 0.180 |
Why?
|
| Portal Vein | 2 | 2016 | 46 | 0.170 |
Why?
|
| Area Under Curve | 5 | 2021 | 238 | 0.170 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 163 | 0.170 |
Why?
|
| Perfusion Imaging | 2 | 2016 | 27 | 0.170 |
Why?
|
| Chemoradiotherapy, Adjuvant | 2 | 2017 | 33 | 0.170 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 193 | 0.170 |
Why?
|
| Asymptomatic Diseases | 2 | 2019 | 43 | 0.170 |
Why?
|
| Purines | 2 | 2021 | 39 | 0.170 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 800 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2023 | 346 | 0.170 |
Why?
|
| Italy | 2 | 2013 | 36 | 0.170 |
Why?
|
| Heart Rate | 3 | 2016 | 568 | 0.170 |
Why?
|
| Pancreas | 3 | 2015 | 225 | 0.160 |
Why?
|
| Terminology as Topic | 2 | 2016 | 141 | 0.160 |
Why?
|
| Rest | 1 | 2019 | 78 | 0.160 |
Why?
|
| Heart Failure | 2 | 2023 | 1180 | 0.160 |
Why?
|
| Prosthesis Failure | 2 | 2016 | 130 | 0.160 |
Why?
|
| Aortic Coarctation | 2 | 2008 | 37 | 0.160 |
Why?
|
| Vasodilator Agents | 2 | 2016 | 138 | 0.160 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 134 | 0.150 |
Why?
|
| Child | 6 | 2019 | 6405 | 0.150 |
Why?
|
| Germany | 4 | 2020 | 67 | 0.150 |
Why?
|
| Injections, Intra-Arterial | 1 | 2017 | 30 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2021 | 310 | 0.150 |
Why?
|
| Infant | 3 | 2019 | 2891 | 0.150 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 546 | 0.140 |
Why?
|
| Child, Preschool | 3 | 2019 | 3187 | 0.140 |
Why?
|
| Angina, Stable | 1 | 2016 | 13 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 80 | 0.140 |
Why?
|
| Angina, Unstable | 1 | 2016 | 50 | 0.140 |
Why?
|
| Cerebral Angiography | 1 | 2017 | 151 | 0.140 |
Why?
|
| Systole | 3 | 2015 | 149 | 0.140 |
Why?
|
| Tachycardia, Ventricular | 2 | 2015 | 153 | 0.140 |
Why?
|
| Fluorine Radioisotopes | 1 | 2016 | 13 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 286 | 0.140 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2016 | 16 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 239 | 0.130 |
Why?
|
| Hepatic Encephalopathy | 1 | 2016 | 25 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2016 | 73 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 1 | 2016 | 84 | 0.130 |
Why?
|
| Intracranial Aneurysm | 1 | 2017 | 87 | 0.130 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2016 | 28 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2015 | 5 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2017 | 328 | 0.130 |
Why?
|
| Colon, Transverse | 1 | 2015 | 2 | 0.130 |
Why?
|
| Sex Factors | 2 | 2019 | 1266 | 0.130 |
Why?
|
| Colon, Ascending | 1 | 2015 | 3 | 0.130 |
Why?
|
| Colon, Descending | 1 | 2015 | 3 | 0.130 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 83 | 0.130 |
Why?
|
| Colon, Sigmoid | 1 | 2015 | 13 | 0.130 |
Why?
|
| Meglumine | 1 | 2015 | 16 | 0.130 |
Why?
|
| Cecal Diseases | 1 | 2015 | 6 | 0.130 |
Why?
|
| Cerebral Infarction | 1 | 2016 | 103 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 536 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 78 | 0.130 |
Why?
|
| Iliac Artery | 1 | 2015 | 44 | 0.130 |
Why?
|
| Cardiac Catheterization | 2 | 2016 | 419 | 0.130 |
Why?
|
| Heart Valves | 1 | 2016 | 171 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2016 | 222 | 0.120 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 47 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2016 | 178 | 0.120 |
Why?
|
| Drug Eruptions | 1 | 2014 | 16 | 0.120 |
Why?
|
| Leukoaraiosis | 1 | 2014 | 14 | 0.120 |
Why?
|
| Respiratory Aspiration | 1 | 2014 | 13 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2015 | 85 | 0.120 |
Why?
|
| Diabetic Angiopathies | 1 | 2016 | 203 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2016 | 222 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 792 | 0.120 |
Why?
|
| Organometallic Compounds | 1 | 2015 | 95 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 567 | 0.120 |
Why?
|
| Reference Values | 3 | 2013 | 579 | 0.120 |
Why?
|
| Edema | 1 | 2014 | 66 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2014 | 47 | 0.120 |
Why?
|
| Aorta | 1 | 2016 | 316 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2015 | 97 | 0.120 |
Why?
|
| After-Hours Care | 1 | 2014 | 17 | 0.120 |
Why?
|
| Breast | 1 | 2015 | 137 | 0.120 |
Why?
|
| Heart Conduction System | 1 | 2015 | 119 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 63 | 0.120 |
Why?
|
| Vascular Malformations | 1 | 2014 | 19 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 56 | 0.120 |
Why?
|
| Intestinal Perforation | 1 | 2014 | 35 | 0.120 |
Why?
|
| Postgastrectomy Syndromes | 1 | 2013 | 2 | 0.120 |
Why?
|
| Decision Making | 1 | 2017 | 410 | 0.120 |
Why?
|
| Gastrectomy | 1 | 2013 | 24 | 0.120 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2014 | 79 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 25 | 0.110 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 306 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2014 | 97 | 0.110 |
Why?
|
| Age Factors | 2 | 2015 | 1864 | 0.110 |
Why?
|
| Genital Diseases, Female | 1 | 2013 | 23 | 0.110 |
Why?
|
| Vena Cava, Superior | 1 | 2013 | 41 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 198 | 0.110 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 10 | 0.110 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 16 | 0.110 |
Why?
|
| Rectal Diseases | 1 | 2013 | 13 | 0.110 |
Why?
|
| Abdominal Wall | 1 | 2013 | 20 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 694 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2013 | 36 | 0.110 |
Why?
|
| Mammography | 1 | 2015 | 310 | 0.100 |
Why?
|
| Seizures | 1 | 2014 | 279 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2020 | 2358 | 0.100 |
Why?
|
| Carcinoma | 1 | 2013 | 215 | 0.100 |
Why?
|
| Triiodobenzoic Acids | 3 | 2016 | 28 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 172 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 508 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2014 | 307 | 0.100 |
Why?
|
| Patient Care Planning | 3 | 2016 | 108 | 0.090 |
Why?
|
| Blood Flow Velocity | 3 | 2017 | 172 | 0.090 |
Why?
|
| Hospitalization | 1 | 2016 | 978 | 0.090 |
Why?
|
| Exercise | 1 | 2016 | 658 | 0.090 |
Why?
|
| Time Factors | 5 | 2019 | 4655 | 0.090 |
Why?
|
| Oxygen | 1 | 2012 | 386 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 208 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2011 | 172 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 237 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2017 | 880 | 0.090 |
Why?
|
| South Carolina | 4 | 2019 | 2752 | 0.090 |
Why?
|
| Mediastinal Cyst | 1 | 2009 | 5 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2009 | 51 | 0.080 |
Why?
|
| Tissue Survival | 1 | 2008 | 22 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2016 | 1615 | 0.080 |
Why?
|
| Medical Errors | 1 | 2009 | 80 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 561 | 0.080 |
Why?
|
| Comorbidity | 3 | 2019 | 1426 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2009 | 157 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2014 | 596 | 0.080 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2008 | 2 | 0.080 |
Why?
|
| Logistic Models | 3 | 2017 | 1420 | 0.080 |
Why?
|
| Telemedicine | 1 | 2016 | 700 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2017 | 2455 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2010 | 229 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2279 | 0.080 |
Why?
|
| Angina Pectoris | 1 | 2008 | 61 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2008 | 42 | 0.080 |
Why?
|
| China | 2 | 2019 | 138 | 0.080 |
Why?
|
| Celiac Artery | 1 | 2007 | 12 | 0.080 |
Why?
|
| Respiration | 2 | 2019 | 91 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 249 | 0.070 |
Why?
|
| Brain | 2 | 2016 | 2176 | 0.070 |
Why?
|
| Filtration | 2 | 2018 | 61 | 0.070 |
Why?
|
| Single-Blind Method | 3 | 2014 | 249 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 383 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2008 | 215 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 1535 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 1038 | 0.070 |
Why?
|
| Early Diagnosis | 2 | 2017 | 122 | 0.070 |
Why?
|
| Risk | 2 | 2020 | 563 | 0.070 |
Why?
|
| Equipment Failure Analysis | 2 | 2016 | 121 | 0.070 |
Why?
|
| Ovary | 2 | 2019 | 99 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 1140 | 0.070 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2016 | 52 | 0.070 |
Why?
|
| Constriction, Pathologic | 2 | 2017 | 236 | 0.060 |
Why?
|
| User-Computer Interface | 2 | 2017 | 230 | 0.060 |
Why?
|
| Equipment Design | 2 | 2016 | 500 | 0.060 |
Why?
|
| Fibrosis | 2 | 2018 | 371 | 0.060 |
Why?
|
| Diastole | 2 | 2015 | 161 | 0.060 |
Why?
|
| Vascular Patency | 2 | 2014 | 122 | 0.060 |
Why?
|
| Acute Disease | 2 | 2016 | 658 | 0.060 |
Why?
|
| Personhood | 1 | 2003 | 4 | 0.060 |
Why?
|
| Brain Death | 1 | 2003 | 34 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1046 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2015 | 453 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 103 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2018 | 1330 | 0.050 |
Why?
|
| Heart Arrest | 1 | 2003 | 113 | 0.050 |
Why?
|
| Peru | 1 | 2021 | 11 | 0.050 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2021 | 6 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 190 | 0.050 |
Why?
|
| Uganda | 1 | 2021 | 41 | 0.050 |
Why?
|
| Tuberculin Test | 1 | 2021 | 16 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2017 | 1040 | 0.050 |
Why?
|
| Violence | 1 | 2003 | 275 | 0.050 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 11 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 69 | 0.050 |
Why?
|
| Biopsy | 2 | 2014 | 540 | 0.040 |
Why?
|
| Time | 1 | 2020 | 57 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2020 | 23 | 0.040 |
Why?
|
| Microcirculation | 1 | 2020 | 77 | 0.040 |
Why?
|
| Acute Pain | 1 | 2020 | 35 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 115 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 83 | 0.040 |
Why?
|
| Douglas' Pouch | 1 | 2019 | 2 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 102 | 0.040 |
Why?
|
| Rectum | 1 | 2019 | 62 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 948 | 0.040 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 81 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2018 | 15 | 0.040 |
Why?
|
| Animals | 4 | 2018 | 20881 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 947 | 0.040 |
Why?
|
| Models, Animal | 1 | 2018 | 252 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 202 | 0.040 |
Why?
|
| Causality | 1 | 2017 | 82 | 0.040 |
Why?
|
| Absorption, Radiation | 1 | 2016 | 4 | 0.040 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 110 | 0.040 |
Why?
|
| Swine | 1 | 2018 | 672 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 277 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 622 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 5300 | 0.040 |
Why?
|
| Breath Holding | 1 | 2016 | 8 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 2016 | 29 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 132 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 168 | 0.030 |
Why?
|
| Biotechnology | 1 | 2016 | 34 | 0.030 |
Why?
|
| Ethiodized Oil | 1 | 2016 | 4 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 70 | 0.030 |
Why?
|
| Ibuprofen | 1 | 2016 | 30 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 109 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2016 | 78 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 100 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 89 | 0.030 |
Why?
|
| Automation | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 866 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 34 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 87 | 0.030 |
Why?
|
| Syncope | 1 | 2014 | 23 | 0.030 |
Why?
|
| Autopsy | 1 | 2014 | 56 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Acute Chest Syndrome | 1 | 2014 | 19 | 0.030 |
Why?
|
| Scimitar Syndrome | 1 | 2014 | 6 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2015 | 48 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2014 | 27 | 0.030 |
Why?
|
| Ischemia | 1 | 2016 | 229 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 164 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 191 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2014 | 27 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 166 | 0.030 |
Why?
|
| Urinary Tract | 1 | 2014 | 10 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 301 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2014 | 134 | 0.030 |
Why?
|
| Necrosis | 1 | 2014 | 239 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 240 | 0.030 |
Why?
|
| Eating | 1 | 2014 | 119 | 0.030 |
Why?
|
| Software Design | 1 | 2013 | 18 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 215 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 301 | 0.030 |
Why?
|
| Global Health | 1 | 2014 | 136 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 2334 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2013 | 27 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 243 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 334 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 849 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 274 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 597 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2013 | 79 | 0.030 |
Why?
|
| Health Behavior | 1 | 2016 | 458 | 0.030 |
Why?
|
| Colectomy | 1 | 2013 | 64 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2013 | 101 | 0.030 |
Why?
|
| Cattle | 1 | 2013 | 475 | 0.030 |
Why?
|
| Reoperation | 1 | 2013 | 467 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 369 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2013 | 318 | 0.020 |
Why?
|
| Sternotomy | 1 | 2010 | 18 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1451 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2550 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.020 |
Why?
|
| Ileum | 1 | 2007 | 28 | 0.020 |
Why?
|
| Jejunum | 1 | 2007 | 26 | 0.020 |
Why?
|
| Duodenum | 1 | 2007 | 47 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 329 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 2800 | 0.020 |
Why?
|